Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

  • Megha Verma,
  • David Beaulieu-Abdelahad,
  • Ghania Ait-Ghezala,
  • Rena Li,
  • Fiona Crawford,
  • Michael Mullan,
  • Daniel Paris

Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD

  • Megha Verma, 
  • David Beaulieu-Abdelahad, 
  • Ghania Ait-Ghezala, 
  • Rena Li, 
  • Fiona Crawford, 
  • Michael Mullan, 
  • Daniel Paris
PLOS
x

The following information is missing from the Funding section: This study was also funded by the Roskamp Foundation.

Reference

  1. 1. Verma M, Beaulieu-Abdelahad D, Ait-Ghezala G, Li R, Crawford F, Mullan M, et al. (2015) Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. PLoS ONE 10(5): e0128224. pmid:26010758